# Oral β-Alanine Supplementation in Patients With COPD

> **NCT02770417** · NA · COMPLETED · sponsor: **Hasselt University** · enrollment: 60 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DIETARY_SUPPLEMENT:** beta-alanine
- **DIETARY_SUPPLEMENT:** placebo
- **OTHER:** control

## Key facts

- **NCT ID:** NCT02770417
- **Lead sponsor:** Hasselt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02770417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02770417, "Oral β-Alanine Supplementation in Patients With COPD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02770417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*